Chest Wall Tuberculosis After Bacillus Calmette-Guérin Vaccination
Pediatr Infect Dis J
.
2022 Nov 1;41(11):e504-e505.
doi: 10.1097/INF.0000000000003676.
Epub 2022 Aug 31.
Authors
Mayu Iwai
1
,
Takashi Fukushima
2
,
Noriyuki Watanabe
3
,
Atsuhiko Ohta
4
,
Atsuko Watanabe
4
,
Takamasa Takii
5
,
Kotaro Mitsutake
6
,
Ryuhei Tanaka
2
,
Yasuhiro Ebihara
7
Affiliations
1
Clinical Laboratory, Saitama Medical University International Medical Center, Saitama, Japan.
2
Department of Pediatric Hematology/Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
3
Clinical Laboratory, Saitama Medical University International, Medical Center, Saitama, Japan.
4
Department of Pediatric Hematology/Oncology, Saitama Medical University International, Medical Center, Saitama, Japan.
5
Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
6
Department of Infectious Diseases and Infection Control, Saitama Medical University International, Medical Center, Saitama, Japan.
7
Clinical Laboratory, Department of Laboratory Medicine, Saitama Medical University International Medical Center, Saitama, Japan.
PMID:
36102718
DOI:
10.1097/INF.0000000000003676
No abstract available
Publication types
Letter
MeSH terms
Adjuvants, Immunologic
BCG Vaccine* / adverse effects
Humans
Thoracic Wall*
Tuberculosis* / prevention & control
Vaccination / adverse effects
Substances
Adjuvants, Immunologic
BCG Vaccine